Geriatrics PRN Focus Session — Getting to the Heart of Dementia: Exploring Novel Therapies and the Heart-Brain Connection
Saturday, October 12, 2024 from 3:30 PM to 5:00 PM MST
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-24-125-L01-P
Activity Type: A Knowledge-Based Activity
This session will discuss novel approaches to detecting, evaluating, and managing early cognitive changes. The session will review the spectrum of cognitive change in persons at risk for dementia. It will describe the interplay between chronic cardiovascular and cerebrovascular conditions and the risk for cognitive change. It will also explore the utility of biomarker evaluation and amyloid-beta treatments for early-stage cognitive changes in patients with cardio and cerebrovascular considerations.
Faculty
![Collin M. Clark, Pharm.D., BCGP, BCPS Collin M. Clark, Pharm.D., BCGP, BCPS](/images/imis/2050216.png) | Moderator: | Collin M. Clark, Pharm.D., BCGP, BCPS | | Clinical Assistant Professor
University at Buffalo School of Pharmacy and Pharmaceutical Sciences
Buffalo, New York | View Biography |
|
Learning Objectives
1. Discuss approaches to detecting, evaluating, and managing early cognitive changes.
2. Review the spectrum of cognitive changes in persons at risk for dementia.
3. Describe the relationship between chronic cardiovascular disease and risk for cognitive decline.
4. Summarize the clinical pharmacist’s role in patient cardiovascular health to reduce the risk for cognitive impairment.
5. Explain the utility of biomarker evaluation in detection of early cognitive changes.
6. Describe appropriate candidates for amyloid-beta therapies and the real-world application.
Early Cognitive Change in Persons at Risk for Dementia3:30 PM to 4:00 PM ![Erica Dominguez, Pharm.D. Erica Dominguez, Pharm.D.](/images/missing_image.png) | Speaker: | Erica Dominguez, Pharm.D. |
|
|
Connecting the Dots Between Cardiovascular Disease and Cognitive Impairment4:00 PM to 4:30 PM ![Kristen M. Cook, Pharm.D., BCACP Kristen M. Cook, Pharm.D., BCACP](/images/imis/1989201.png) | Speaker: | Kristen M. Cook, Pharm.D., BCACP | | Clinical Associate Professor, University of Nebraska Medical Center College of Pharmacy, Omaha, NE | View Biography |
|
|
Utility of Biomarkers and Amyloid-Beta Therapy for Early-Stage Cognitive Change4:30 PM to 5:00 PM ![Jeffrey T. Sherer, Pharm.D., MPH, BCGP, BCPS Jeffrey T. Sherer, Pharm.D., MPH, BCGP, BCPS](/images/imis/1955822.png) | Speaker: | Jeffrey T. Sherer, Pharm.D., MPH, BCGP, BCPS | | Clinical Professor, University of Houston College of Pharmacy, Houston, Texas | View Biography |
|
|